Cutaneous metastasis of prostatic adenocarcinoma: A cautionary tale

Journal of Cutaneous Pathology

Volumn 38, Issue 6, 2011, Pages 521-524

  Rattanasirivilai, Anongluck ^a   Kurban, Amal ^a   Lenzy, Yolanda M ^a   Yaar, Ron ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

adenocarcinoma; cutaneous; metastasis; prostate specific antigen

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROSTATE SPECIFIC ANTIGEN; PROTEIN TYROSINE PHOSPHATASE;

ADENOCARCINOMA; AGED; ARTICLE; BIOSYNTHESIS; CASE REPORT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PATHOLOGY; PROSTATE TUMOR; SKIN TUMOR; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; AGED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN TYROSINE PHOSPHATASES; SKIN NEOPLASMS; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 79955540925     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01677.x     Document Type: Article

References (10)

1. Jemal A, Siegel R, Ward E, et al., Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71.
2. Venable DD, Hastings D, Misra RP., Unusual metastatic patterns of prostate adenocarcinoma. J Urol 1983; 130: 980.
3. Cooper EH, Robinson MR, Whelan P, Ferro MA., Tumor markers in prostate cancer. Cancer 1992; 70 (Suppl. 1): 225.
4. Paner GP, Luthringer DJ, Amin MB., Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med 2008; 132: 1388.
5. Schwartz RA., Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33 (2 Pt 1): 161.
6. Wang SQ, Mecca PS, Myskowski PL, Slovin SF., Scrotal and penile papules and plaques as the initial manifestation of a cutaneous metastasis of adenocarcinoma of the prostate: case report and review of the literature. J Cutan Pathol 2008; 35: 681.
7. Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA., Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol 2000; 113: 383.
8. Torenbeek R, Lagendijk JH, Van Diest PJ, Bril H, van de Molengraft FJ, Meijer CJ., Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology 1998; 32: 20.
9. Goldstein NS., Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol 2002; 117: 471.
10. Freeman NJ, Doolittle C., Elevated prostate markers in metastatic small cell carcinoma of unknown primary. Cancer 1991; 68: 1118.